The Act would deschedule and legalize cannabis with strong equity provisions, from expungement to opening up loan programs for small business owners.
Charlotte’s Web: FDA’s CBD regs “potential revenue catalyst” • Cresco scales back Origin House deal • & more…
An excerpt from the November 14 edition of the Cannabis Wire Daily newsletter.
Losses widened year-over-year, while net revenue declined 15 percent from the previous quarter, for the world’s highest-valued cannabis company.
For decades, cannabis has been sold in coffee shops, but illegal to grow. A government experiment, approved by the Senate this week, aims to resolve that tension.
An excerpt from the November 13 edition of the Cannabis Wire Daily newsletter.
Nazma Muller is entering her fifth week of protest outside Trinidad and Tobago’s Parliament, as she pushes hard for cannabis law reform, and to include local players in an emerging legal industry.
Today, guidance was released for cannabis companies due to the "higher than usual crossover of financial interests" in the industry.
Sativex and Epidyolex were approved for reimbursement by the NHS for some conditions. But health officials say product costs are too high, and benefits too low, for patients with chronic pain.
The Centers for Disease Control and Prevention released a number of updates Friday, and emphasized the “much greater risk” of consuming THC vape products from “informal sources.”
Cannabis Wire caught up with the Canopy Growth founder and former CEO on his decision to join Vireo Health as executive chairman.